GLYCINE Drug Patent Profile
✉ Email this page to a colleague
When do Glycine patents expire, and what generic alternatives are available?
Glycine is a drug marketed by B Braun, Baxter Hlthcare, Hospira, and Otsuka Icu Medcl. and is included in four NDAs.
The generic ingredient in GLYCINE is glycine. There are thirty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glycine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GLYCINE?
- What are the global sales for GLYCINE?
- What is Average Wholesale Price for GLYCINE?
Summary for GLYCINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| What excipients (inactive ingredients) are in GLYCINE? | GLYCINE excipients list |
| DailyMed Link: | GLYCINE at DailyMed |
Recent Clinical Trials for GLYCINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Janssen Research & Development, LLC | PHASE1 |
| National Institute on Aging (NIA) | Phase 4 |
| Vanderbilt University Medical Center | Phase 4 |
Medical Subject Heading (MeSH) Categories for GLYCINE
Anatomical Therapeutic Chemical (ATC) Classes for GLYCINE
US Patents and Regulatory Information for GLYCINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | GLYCINE 1.5% IN PLASTIC CONTAINER | glycine | SOLUTION;IRRIGATION | 016784-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Otsuka Icu Medcl | GLYCINE 1.5% IN PLASTIC CONTAINER | glycine | SOLUTION;IRRIGATION | 018315-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Baxter Hlthcare | GLYCINE 1.5% IN PLASTIC CONTAINER | glycine | SOLUTION;IRRIGATION | 018522-001 | Feb 19, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
